Aptose Biosciences Inc. (APTO)
NASDAQ: APTO · Real-Time Price · USD
0.408
+0.003 (0.77%)
At close: Sep 18, 2024, 4:00 PM
0.390
-0.018 (-4.39%)
After-hours: Sep 18, 2024, 4:36 PM EDT

Aptose Biosciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Net Income
-40.29-51.21-41.82-65.35-55.24-26.28
Upgrade
Depreciation & Amortization
0.430.470.530.620.610.61
Upgrade
Loss (Gain) From Sale of Assets
0.08-0.02---
Upgrade
Stock-Based Compensation
2.033.655.2112.9521.442.3
Upgrade
Other Operating Activities
0.090.09-0.027.520.090.39
Upgrade
Change in Accounts Payable
3.61-0.287.61-0.470.210.65
Upgrade
Change in Other Net Operating Assets
-3.232.69-3.841.43-1.010.77
Upgrade
Operating Cash Flow
-37.34-44.59-32.32-43.3-33.89-21.56
Upgrade
Capital Expenditures
--0.03-0.02-0.21-0.08-0.1
Upgrade
Investment in Securities
14.899.9930.09-3512.71-17.27
Upgrade
Investing Cash Flow
14.919.9630.07-35.2112.63-17.37
Upgrade
Issuance of Common Stock
22.536.910.120.2358.98103.89
Upgrade
Other Financing Activities
-0.17----0.17-0.44
Upgrade
Financing Cash Flow
22.366.910.120.2358.81103.45
Upgrade
Foreign Exchange Rate Adjustments
-0-00.010.010.02
Upgrade
Net Cash Flow
-0.07-27.72-2.14-78.2837.5564.54
Upgrade
Free Cash Flow
-37.34-44.62-32.35-43.52-33.97-21.66
Upgrade
Free Cash Flow Per Share
-3.36-6.61-5.26-7.33-6.23-6.48
Upgrade
Levered Free Cash Flow
-22.32-25.82-16.6-26.03-13.14-12.17
Upgrade
Unlevered Free Cash Flow
-22.27-25.82-16.6-26.03-13.14-12.17
Upgrade
Change in Net Working Capital
-0.85-2.81-4.32-1.520.26-1.81
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.